OTC:NWBO | Free Cash Flow | NORTHWEST BIOTHERAPEUTICS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$12.51M$129,000.00-$12.64M
2025-12-31-$14.76M$905,000.00-$15.67M-1128.89%
2025-03-31-$9.42M$93,000.00-$9.51M
2024-12-31-$20.18M$78,000.00-$20.26M
2024-03-31-$12.41M$239,000.00-$12.65M
2023-12-31-$16.96M
2023-03-31-$11.24M
2022-12-31-$8.85M
2022-03-31-$12.97M
2021-12-31-$11.25M
2021-03-31-$13.25M
2020-12-31-$10.2M
2020-03-31-$7.54M
2019-12-31-$5.98M
2019-03-31-$9.75M
2018-12-31-$14.18M
2018-03-31-$4.79M
2017-12-31-$14.79M
2017-03-31-$12.28M
2016-12-31-$14.1M
2016-09-30$9.8M
2016-03-31-$17.6M
2015-12-31-$22.13M
2015-09-30$11.8M
2015-03-31-$17.58M$1.13M-$18.72M
2014-12-31-$18.6M
2014-03-31-$10.56M$0.00-$10.56M
2013-12-31-$14.6M-$55,000.00-$14.66M
2013-03-31-$7.07M$0.00-$7.07M
2012-12-31-$8.25M$0.00-$8.25M
2012-09-30$6.1M
2012-03-31-$3.54M$0.00-$3.54M
2011-12-31-$4.56M$18,000.00-$4.57M
2011-03-31-$1.5M$0.00-$1.5M
2010-12-31-$144,000.00$0.00-$144,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$44.76M$1.5M-$46.27M
2024-12-31-$57.02M$1.01M-$58.03M
2023-12-31-$53.64M
2022-12-31-$52.78M
2021-12-31-$38.3M
2020-12-31-$32.09M
2019-12-31-$31.86M$171,000.00-$32.03M
2018-12-31-$34.59M
2017-12-31-$36.5M
2016-12-31-$55.65M
2015-12-31-$78.61M
2014-12-31-$54.58M
2013-12-31-$37.8M-$1,000.00-$37.8M
2012-12-31-$22.75M$31,000.00-$22.79M
2011-12-31-$14.71M$49,000.00-$14.76M
2010-12-31-$6.38M$41,000.00-$6.42M